Navigation Links
Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
Date:1/7/2008

ves towards irreversible blindness. Classically in affected people, the retinal rod photoreceptors responsible for night vision and side vision slowly degenerate, first leading to night blindness. As the disorder progresses, the cone photoreceptors degenerate also and their loss is responsible of a narrowing of the peripheral field of vision which progressively worsens to become "tunnel-like". During the last phase of the disease, the central vision can decrease until the patient becomes blind.

RP usually appears in teenagers and young adults but may sometimes be present from early childhood and generally progresses over several decades. However, in extreme cases the disease may evolve rapidly over two decades. In the European Community, 150 000 patients are affected by this disorder.

RP is a genetic disorder. The inheritance pattern is variable and can be either autosomal dominant, autosomal recessive or X-linked recessive. Most genes for RP cause only a small proportion of cases, exceptions being the rhodopsin gene, which leads to about 25% of dominant RP. Overall, approximately 40% of cases of RP are due to genes that are as yet undiscovered.

About RdCVF

RdCVF (Rod derived Cone Viability Factor) is a protein that is produced by the rods and is necessary for the functionality and the survival of the cones. RdCVF was first identified by Pr. Jos Sahel's team at INSERM U592. The original work was published in Nature Genetics in 2004.

In RP, preventing cone cell death is a very promising therapeutic approach as vision can remain substantial in patients with 95% cone loss. This offers greater hope for a positive outcome from a strategy aimed at preserving the remaining cones in RP patients and simultaneously broadens the window for therapeutic intervention.

About FOVEA Pharmaceuticals

Fovea Pharmaceuticals SA (Fovea) is a privately-held biopharmaceutical company specialized in development and commercialization of drugs f
'/>"/>

SOURCE Fovea Pharmaceuticals SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
2. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
3. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
4. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
5. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
6. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
7. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
10. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... -- ASSESS shows   plasma circulating tumour ... alternative to tumour biopsy   IGNITE supports ... NSCLC   AstraZeneca today presented results from two ... (ctDNA) testing for epidermal growth factor receptor (EGFR) mutation status ... (NSCLC) in clinical practice. [ 1 ] ...
(Date:4/17/2015)... DETROIT , April 17, 2015  In Detroit, where ... infant mortality rate is two and one half times of ... Nearly 6 of 10 infants that die in ... are sobering statistics that Covenant Community Care, a faith-based, charitable ... is poised to change thanks to a charitable donation by ...
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... "Medical Oxygen Systems - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Oxygen Systems in ... Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving ... US, Canada , Japan ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2
(Date:4/18/2015)... Montreal, Canada (PRWEB) April 18, 2015 ... of emotions on food choices when he uttered, “Tell ... what you are.” Using food to cope with stress ... research by Queendom.com indicates otherwise. Data collected ... both genders fall victim to emotional eating, but for ...
(Date:4/17/2015)... Lynnwood, WA (PRWEB) April 17, 2015 ... seat cushions is introducing two new products to help ... seeking low back pain relief are the second most ... was our first product, designed specifically to help relieve ... the Comfort Cushion, and thousands of happy customers later, ...
(Date:4/17/2015)... 17, 2015 “We have seen healing, a ... past and present,” said Chaplain Shawn Kafader of Friendship Village. ... like they had anything to contribute have created beautiful pieces ... a new art therapy program that was launched to benefit ... student from School of the Art Institute in Chicago, worked ...
(Date:4/17/2015)... 17, 2015 Representatives Jim Himes (D-CT) ... Treatment Act HR 1849 in congress on April 16, ... treatment for patients with the genetic disease. , ... would be the first to create a federally led ... of hereditary hemorrhagic telangiectasia. This would effectively prevent premature ...
(Date:4/17/2015)... Fla. (PRWEB) April 17, 2015 Most ... of dental restoration units are made overseas by foreign ... Additionally, domestic labs remain unregulated in more than 40 ... The National Association of Dental Laboratories has ... to raise awareness among patients about the consequences that ...
Breaking Medicine News(10 mins):Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Healing At Friendship Village Due To Art Therapy 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:National Association Urges Transparency in Dental Industry 2
... and treatment of genitourinary cancers were released today in advance ... 17-19, 2011, at the Orlando World Center Marriott in Orlando, ... a media presscast (press briefing via live webcast): ... death for men with low initial PSAs: A large prostate ...
... TUESDAY, Feb. 15 (HealthDay News) -- Men with prostate cancer may ... pattern baldness at the age of 20 than those without prostate ... their hair in their 30s or 40s do not appear to ... hair loss starts in their 20s do not face a higher ...
... of all the imaging costs ordered for 2,068 orthopaedic patient ... a new study presented today at the 2011 Annual Meeting ... For many years now, some physicians have ordered specific ... a patient, largely to protect themselves from a lawsuit. ...
... to lose hair at the age of 20 are more likely ... screening for the disease, according to a new study published online ... The French study compared 388 men being treated for ... found that those with the disease were twice as likely as ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) ... restaurants doesn,t appear to inspire teenagers and parents of ... Researchers who studied menu choices at four fast-food restaurant ... New York City said the legislation did little to ...
... An estimated 10 million Americans suffer from knee osteoarthritis ... disability in the US. Due to obesity and symptomatic knee ... the equivalent of 86 million healthy years of life, concluded ... potential gains in quality and quantity of life that could ...
Cached Medicine News:Health News:Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Health care spending: Study shows high imaging costs for defensive purposes 2Health News:Health care spending: Study shows high imaging costs for defensive purposes 3Health News:Losing hair at 20 is linked to increased risk of prostate cancer in later life 2Health News:Losing hair at 20 is linked to increased risk of prostate cancer in later life 3Health News:Calorie Labels Don't Affect Kids' Fast-Food Choices 2Health News:Calorie Labels Don't Affect Kids' Fast-Food Choices 3Health News:Obesity and knee osteoarthritis shorten healthy years of life 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: